Pfizer
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.
RELATED ARTICLES
Researcher Profile: Dr. Yasmeen Agosti
At Pfizer, Yasmeen works to develop maternal vaccines that have the potential to help prevent diseas…
READ MORE
Researcher Profile: Dr. Marie-Claire Peakman
Dr. Marie-Claire Peakman always knew she wanted to make a difference in the world.
READ MORE
Why innovation is vital: My battle with C. difficile
Simon Jenkins, who suffered from C. diff, shares his story and hope for future treatments.
READ MORE
Researcher Profile: Michael Pride
To demonstrate the incredible work pursued by America's biopharmaceutical researchers, we're sharing…
READ MORE
I Just Want to Show Other Patients that Anything is Possible
Today is World Duchenne Awareness Day, which aims to raise awareness for people living with Duchenne…
READ MORE
Researcher Profile: Jane Owens
Dr. Owens is a senior director who manages rare muscle disease research projects in Pfizer's Rare Di…
READ MORE
Vaccines: Cutting Health Care Costs While Saving Countless Lives
In the United States, 16 diseases are now preventable as a result of childhood vaccines, resulting i…
READ MORE
Researcher Profile: Ted Johnson
Ted Johnson has spent his career working to find better and more innovative treatments for cancer.
READ MORE
Lung Cancer Gets Personal
Lung cancer counts for 25% of all cancer deaths in the U.S. That's why every day, researchers search…
READ MORE
Researcher Profile: Kelly Knee
As a principal scientist working on sickle cell disease in the Rare Disease Research Unit (RDRU) at…
READ MORE
Recognizing Diversity in Clinical Trials
Every time you take a medicine – even if it's just for a headache – you are benefitting from the res…
READ MORE
Battling Cancer Together
At age 24, medical student Matt Hiznay was diagnosed with stage IV lung cancer.
READ MORE
Building "Smart Bombs" to Attack Cancer
Biopharmaceutical researchers are investigating a new type of therapy that has the potential to atta…
READ MOREPOPULAR ARTICLES
Can We Afford the New Era of Medicine?
Innovative treatments require innovative partnerships. America's Biopharmaceutical Companies and insurers are partnering to get the right medicine in the hands of patients who need them.
READ MORE
Researcher Profile: Jirong Lu
Dr. Jirong Lu, a distinguished research fellow at Eli Lilly and Company (Lilly), traces the beginnings of her career to a high school fascination with chemistry.
READ MORE
Policy Solutions to Push Progress Forward
We are in a new era of medical discovery and have the potential to revolutionize the treatment of costly and debilitating diseases. But we must not take this progress for granted.
READ MORE
The Greatest Gift of All: Hope
My son Parker's journey with juvenile arthritis (JA) began 10 years ago when he was in elementary school.
READ MORE
Migraine: More than Just a Bad Headache
Migraine is a debilitating neurological disease that is often misunderstood by those who do not suffer symptoms, according to the Migraine Impact Report, a new survey recently released by Eli Lilly and Company and conducted by Nielsen.
READ MORE
Washington is considering policy changes that could threaten innovation
New policy proposals in Washington threaten to hamstring investment in innovation and jeopardize breakthroughs.
READ MORE
Tackling Neurological Disorders in New Ways
Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.
READ MORE